DYSARTHRIA

Dysarthria

Dysarthria

Introduction

Dysarthria is a disturbance in the articulation of phonemes originated from the nervous system injuries, diseases or muscle nerve responsible for speech (tongue, pharynx and larynx). A nervous system disorder causes dysarthria, and motor disorder rather than a language itself. Dysarthria is a speech disorder, based on a condition neurological. The deterioration in a sector of the nervous system responsible for issuing the speech can occur anywhere in tracts ranging from the brain to the muscle itself. Mismatches in the innervations of these muscles (Neurogenic disorders), the function of the muscle itself (disorders or motor coordination) are defects and voice by decreased muscle strength of the organs muscular and respiratory disorders in the muscle tone or involuntary movements.

Discussion and Analysis

Many patients with a DSM-IV diagnosis of Dysarthria have a history of psychosomatic disorders. Guidelines for appropriate pharmacotherapy and implementation of psychotherapy in this subpopulation are nonexistent; having this type of information available to psychologists and psychiatrists may improve patient outcomes and decrease re-hospitalization. Pharmacists will have a reference tool in order to reduce the incidences of poly pharmacy and potential adverse events, as well as improving efficacy and outcomes for patients with optimized drug therapy recommendations. Many classes of antipsychotic medications; known for their potentially negative side effect profiles and additive adverse effects. Identifying and utilizing the most efficacious strategies (pharmacologic and non-pharmacologic) to manage to underlie issues of abuse within this subpopulation may improve overall therapeutic outcomes with the lowest potential for adverse events.

Methods Used for Analysis

For the control and experimental groups, documentation of monthly brief psychiatric rating scale (BPRS) scores, the number of psychotropic medications along with daily dosages, length of pharmacotherapy and class of agents included. Documentation of cognitive readiness for individual psychotherapy and group (activities, discussions, verbal processing, etc.), along with documentation of community outings may be utilized to assess the patient's progress toward therapeutic goals. Additionally, agents used for PRN interventions will assess (frequency, dose, and class) for their impact on clinical outcomes. The study will report any observable trends seen with responses to various pharmacotherapy and psychotherapy regimens, as well as influences or patterns of abuse on outcomes for patients diagnosed with dysarthria.

Characteristics of Dysarthria

The concept of dysarthria has not been approved by the various authors, and efforts have focused on diagnostics for exclusion of conditions that could not be framed within this category. Dysarthria is generally applied to children with severe language disorder. Dysarthria is a form of chronic psychological disorder that may cause deafness, mental retardation, motor impairment, emotional disorders or personality disorders, if not treated effectively. The dysarthria is characterized by severely impaired language development in intellectually normal children older than 5 years. The symptoms may cater both the understanding and the language issue. The complication of this disorder is difficult to explain as it is representing psychological problems, sensory, motor or neurological damage. In addition, this disorder engulfs several problems; such as, scattered attention, isolation, and abnormal emotional behavior.

It is necessary to make a differential diagnosis as the disorder may cause ...